← Human Trials & Peer-Reviewed Studies

The significance of the source of zinc and its anti-VSC effect.

Plain-language guide to PMID 12090459 (2002): randomized controlled trial of Zinc and Zinc Acetate in 10 volunteers.

Key Facts

PMID
12090459
Journal
International dental journal
Year
2002
Study type
Randomized Controlled Trial
Authors
Rölla G et al. (3 authors)
DOI
10.1002/j.1875-595x.2002.tb00931.x

What This Study Did, in Plain Language

What Was Tested

Researchers studied Zinc and Zinc Acetate in this randomized controlled trial publication.

To examine whether zinc salts with low stability constants were more suitable as sources of zinc in zinc lozenges than zinc salts with high stability constants.

The former provide free zinc ions upon dissolution in water, whereas the latter provide few such ions.

Who Took Part

According to the abstract, 10 volunteers were involved.

PubMed indexes the participants as adults, both men and women.

A test panel of 10 volunteers used the different lozenges randomly.

How the Study Was Run

The design is described as randomized.

Random assignment meant chance, not the researchers, decided who got Zinc and who got the comparison, which limits bias.

Identical lozenges were produced which contained either zinc acetate, zinc gluconate (low stability constants), zinc citrate or amino-acid chelated zinc (extremely high stability constants).

All the lozenges contained 0.1 per cent of zinc.

VSC were measured by GC.

What Was Measured

Topics PubMed links to this paper include Amino Acids, Analysis of Variance, Chelating Agents, Chromatography, Gas, Citrates, Cysteine and Gluconates.

What This Means in Plain Language

The paper is a randomized study of Zinc and Zinc Acetate in 10 volunteers.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2002 (International dental journal), a journal based in England.

More context: the related Vitamin D, K2, Magnesium and Zinc library page, all human trials.

Related Library Page

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.